340B Drug Pricing Program
The Centers for Medicare & Medicaid Services (CMS) July 15 released its calendar year (CY) 2023 outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) proposed rule that would increase OPPS rates by a net 2.7% in CY 2023 compared to CY 2022.
For three decades, the 340B drug pricing program has enabled hospitals that serve high numbers of low-income patient populations to stretch scarce federal resources and provide more comprehensive care to their patients and communities.
The Centers for Medicare & Medicaid Services July 15 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system rates by a net 2.7% in calendar year 2023 compared to 2022.
Stacey Hughes
Executive Vice President
ºÚÁÏÕýÄÜÁ¿ Association
July 15, 2022
The AHA, along with other national hospital groups, is running a new digital ad campaign promoting to policymakers and influencers the benefits of the 340B program to patients and communities.
AHA last week asked the Department of Health and Human Services to ensure hospitals quickly receive the funding to which they are entitled under the June 15 Supreme Court decision in ºÚÁÏÕýÄÜÁ¿ Association v. Becerra, without penalizing the rest of the hospital field.
The AHA, 340B Health, America’s Essential Hospitals, Association of American Medical Colleges, and Children’s Hospital Association yesterday filed a friend-of-the-court brief urging the U.S. Courts of Appeals for the 3rd Circuit to require drug companies to fulfill their legal obligations to…
The AHA, 340B Health, America’s Essential Hospitals, Association of American Medical Colleges, and Children’s Hospital Association yesterday filed a friend-of-the-court brief urging the U.S. Courts of Appeals for the 3rd Circuit to require drug companies to fulfill their legal obligations to…
AHA last week asked the Department of Health and Human Services to ensure hospitals quickly receive the funding to which they are entitled under last week’s Supreme Court decision in ºÚÁÏÕýÄÜÁ¿ Association v. Becerra.
The Supreme Court of the United States unanimously ruled in favor of the AHA and others that the Department of Health and Human Services’ (HHS) policy to significantly cut payments by nearly 30% for certain hospitals that participate in the 340B Drug Pricing Program lacked statutory authority and…